Peter Boström - UTU Research Portal

Peter Boström

- Associate Professor,
Surgery (Department of Clinical Medicine)

peter.bostrom@utu.fi

: https://orcid.org/0000-0003-3647-0015

6 of 12

Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures (2020)
- Cellular Oncology
Kähkönen TE, Toriseva M, Petruk N, Virta AR, Maher A, Eigeliene N, Kaivola J, Boström P, Koskivuo I, Nees M, Tuomela JM, Ivaska KK, Härkönen PL
Eturauhassyövän entsyymikuvantaminen PET-menetelmällä (2020)
- Duodecim
Seppänen M, Boström PJ, Minn H, Kemppainen J
Familial aggregation of testicular cancer among early-onset cancer survivors. A prospective observational cohort data from Finland (2020)
- Cancer Epidemiology
Heikki Seikkula, Elli Hirvonen, Antti Kaipia, Peter J Boström, Nea Malila, Janne Pitkäniemi
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment? (2020)
- European Urology
van Rhijn BWG, Mertens LS, Mayr R, Bostrom PJ, Real FX, Zwarthoff EC, Boormans JL, Abas C, van Leenders GJLH, Götz S, Hippe K, Bertz S, Neuzillet Y, Sanders J, Broeks A, van der Heijden MS, Jewett MAS, Marquez M, Stoehr R, Zlotta AR, Eckstein M, Soorojebally Y, Roshani H, Burger M, Otto W, Radvanyi F, Sirab N, Pouessel D, Wullich B, van der Kwast TH, Malats N, Hartmann A, Allory Y, Zuiverloon TCM
Impact of biparametric prebiopsy prostate magnetic resonance imaging on the diagnostics of clinically significant prostate cancer in biopsy naïve men (2020)
- Scandinavian Journal of Urology
Knaapila J, Autio V, Jambor I, Ettala O, Verho J, Kiviniemi A, Taimen P, Perez IM, Aronen HJ, Syvänen KT, Boström PJ
Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor (2020)
- European Urology Oncology
Gregory J Nason, Michael A S Jewett, Peter J Boström, Hanan Goldberg, Aaron R Hansen, Philippe L Bedard, Jeremy Sturgeon, Padraig Warde, Peter Chung, Lynn Anson-Cartwright, Joan Sweet, Eshetu G Atenafu, Martin O'Malley, Robert J Hamilton
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (2020)
- New England Journal of Medicine
Shore ND, Saad F, Cookson MS, George DJ, Saltzstein DR, Tutrone R, Akaza H, Bossi A, van Veenhuyzen DF, Selby B, Fan X, Kang V, Walling J, Tombal B; for the HERO Study Investigators
Palliative MRI-guided transurethral ultrasound ablation for symptomatic locally advanced prostate cancer (2020)
- Scandinavian Journal of Urology
Mikael Anttinen, Pietari Mäkelä, Pertti Nurminen, Eemil Yli-Pietilä, Visa Suomi, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström
Prediction of prostate cancer aggressiveness using 18 F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI (2020)
- Scientific Reports
Movahedi P, Merisaari H, Perez IM, Taimen P, Kemppainen J, Kuisma A, Eskola O, Teuho J, Saunavaara J, Pesola M, Kähkönen E, Ettala O, Liimatainen T, Pahikkala T, Boström P, Aronen H, Minn H, Jambor I
Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy (2020)
- International Journal of Molecular Sciences
Thorsten H Ecke, Adisch Kiani, Thorsten Schlomm, Frank Friedersdorff, Anja Rabien, Klaus Jung, Ergin Kilic, Peter Boström, Minna Tervahartiala, Pekka Taimen, Jan Gleichenhagen, Georg Johnen, Thomas Brüning, Stefan Koch, Jenny Roggisch, Ralph M Wirtz
Prospective study on the effect of short-term androgen deprivation therapy on PSMA uptake evaluated with 68Ga-PSMA-11 PET/MRI in men with treatment-naïve prostate cancer (2020)
- European Journal of Nuclear Medicine and Molecular Imaging
Ettala O, Malaspina S, Tuokkola T, Luoto P, Löyttyniemi E, Boström PJ, Kemppainen J
Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques (2020)
- Journal of Magnetic Resonance Imaging
Ileana Montoya Perez, Ivan Jambor, Tapio Pahikkala, Antti Airola, Harri Merisaari, Jani Saunavaara, Saeid Alinezhad, Riina-Minna Väänänen, Terhi Tallgrén, Janne Verho, Aida Kiviniemi, Otto Ettala, Juha Knaapila, Kari T. Syvänen, Markku Kallajoki, Paula Vainio, Hannu J. Aronen, Kim Pettersson, Peter J. Boström, Pekka Taimen
Re: Antonio C. Westphalen, Charles E. McCulloch, Jordan M. Anaokar, et al. Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 2020;296:76–84: Can the Positive Predictive Value of Prostate MRI in Correlation with Biopsy Findings be Interpreted Without Diving into Details? (2020)
- European Urology Oncology
Ivan Jambor, Ugo G Falagario, Alberto Martini, David Eldred-Evans, Hashim U Ahmed, Peter J Boström; on behalf of the PROMOD Study Group
Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4: Can Patient-derived Cancer Models Change the Costliest Cancer Type? (2020)
- European Urology
Kimmo Kettunen, Peter Boström, Pekka Taimen
Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer: 12-Month Functional and Oncological Results (2020)
- European Urology Open Science
Mikael Anttinen, Pietari Mäkelä, Antti Viitala, Pertti Nurminen, Visa Suomi, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström
Survival and mortality of elderly men with localized prostate cancer managed with primary androgen deprivation therapy or by primary observation (2020)
- BMC Urology
Seikkula H, Boström PJ, Seppä K, Pitkäniemi J, Malila N, Kaipia A
Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial (2020)
- World Journal of Urology
Sell V., Ettala O., Montoya Perez I., Järvinen R., Pekkarinen T., Vaarala M., Seppänen M., Liukkonen T., Marttila T., Aaltomaa S., Kaasinen E., Boström P.J.
Uusia työkaluja paikallisesti edenneen ja etäpesäkkeisen eturauhassyövän lääkehoitoon (2020)
- Duodecim
Virtanen V, Rautiola H, Poutanen M, Boström PJ, Minn H, Sundvall M.
Vasectomy and the risk of prostate cancer in a Finnish nationwide population-based cohort (2020)
- Cancer Epidemiology
Seikkula H, Kaipia A, Hirvonen E, Rantanen M, Pitkäniemi J, Malila N, Boström PJ
Adverse Events During Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer (2019)
- Bladder Cancer
Salminen Antti P, Montoya Perez Ileana, Klén Riku, Ettala Otto O, Syvänen Kari T, Elo Laura L, Boström Peter J